The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
benzyl (S)-1-((S)-2-((S)-1-fluoro-6-guanidino-2-oxohexan-3-ylcarbamoyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-ylcarbamate ID: ALA4560183
PubChem CID: 126678550
Max Phase: Preclinical
Molecular Formula: C29H37FN6O5
Molecular Weight: 568.65
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF
Standard InChI: InChI=1S/C29H37FN6O5/c30-18-25(37)22(13-7-15-33-28(31)32)34-26(38)24-14-8-16-36(24)27(39)23(17-20-9-3-1-4-10-20)35-29(40)41-19-21-11-5-2-6-12-21/h1-6,9-12,22-24H,7-8,13-19H2,(H,34,38)(H,35,40)(H4,31,32,33)/t22-,23-,24-/m0/s1
Standard InChI Key: SJQUCISUQHPEBG-HJOGWXRNSA-N
Molfile:
RDKit 2D
41 43 0 0 0 0 0 0 0 0999 V2000
22.4109 -28.0156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1294 -26.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7907 -26.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5447 -25.5436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7284 -25.5371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4701 -26.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4844 -27.5531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4920 -26.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2948 -29.2098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2873 -30.0249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5743 -30.4234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2055 -26.3354 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9068 -26.7515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6162 -26.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8992 -27.5666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6011 -27.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5935 -28.7937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6238 -25.5332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3206 -26.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0316 -26.3598 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.9902 -30.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1249 -27.6112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8303 -28.0237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7095 -27.6033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9995 -28.0080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9950 -28.8252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4043 -28.8328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2941 -27.5955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5841 -28.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8787 -27.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8867 -26.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1821 -26.3584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4711 -26.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4692 -27.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1744 -27.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1087 -29.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0991 -30.0638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8026 -30.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5146 -30.0749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5185 -29.2535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8143 -28.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
8 12 1 0
14 18 2 0
3 8 1 1
8 7 2 0
9 10 1 0
10 11 2 0
12 13 1 0
13 14 1 0
13 15 1 6
15 16 1 0
16 17 1 0
17 9 1 0
14 19 1 0
19 20 1 0
10 21 1 0
2 22 1 0
1 22 1 0
22 23 2 0
1 24 1 0
24 25 1 0
25 26 2 0
1 27 1 6
25 28 1 0
28 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
27 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 568.65Molecular Weight (Monoisotopic): 568.2809AlogP: 1.80#Rotatable Bonds: 14Polar Surface Area: 166.71Molecular Species: BASEHBA: 6HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.55CX Basic pKa: 11.89CX LogP: 1.60CX LogD: -0.48Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.13Np Likeness Score: -0.18
References 1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428 ] [10.1016/j.bmcl.2019.03.046 ]